Plant Comparison
Horse Chestnut vs Lesser Burdock
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Horse Chestnut and Lesser Burdock: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Horse Chestnut | Lesser Burdock | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 1/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
| Swelling / fluid retention | 7/10 | 1/10 | Stronger for Horse Chestnut |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The active mixture responsible for the venotonic and anti-oedematous effects; extracts are standardised to it. Escin is available as oral drages and a transdermal gel, with efficacy shown in chronic venous insufficiency and blunt-trauma injury.
The major storage carbohydrate; a prebiotic fibre.
Anti-inflammatory and antioxidant constituents.
Antimicrobial and antioxidant constituents.
Pharmacological Actions
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Anti-oedematous and anti-inflammatory - escin reduces vascular permeability in inflamed tissue and exerts venotonic effects on veins
Escin, the triterpene saponin of Aesculus hippocastanum, induces apoptosis and cell-cycle arrest and chemosensitizes breast, hepatocellular, lung and pancreatic cancer cells (preclinical, including in vivo xenograft models).
Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
Lesser burdock (Arctium minus) leaf, flower and root extracts (rich in arctiin/arctigenin and chlorogenic acid) are cytotoxic to breast and liver cancer cells, including multidrug-resistant tumour lines (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
Escin shows antiproliferative and pro-apoptotic activity and enhances chemotherapy/immunotherapy efficacy in breast (MCF-7), hepatocellular, lung and pancreatic cancer models; it modulates NF-kappaB, p53, p38 MAPK/ERK and PD-L1 (preclinical).
Relief of haemorrhoid symptoms (venotonic)
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
inferred from anti-inflammatory action
Chronic venous insufficiency - reduces leg pain, swelling (oedema), heaviness and itching; supports varicose veins
Sebaceous-gland regulator - helps balance skin oil (acne); Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
inferred from anti-inflammatory action
Arctium minus extracts show dose-dependent cytotoxicity against MCF-7 and MDA-MB-231 breast cancer and HepG2 liver cancer cells and are active against both sensitive and multidrug-resistant tumour cell lines (preclinical).
Mild diuretic supporting elimination ('detox', traditional); Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
inferred from anti-inflammatory action
Traditional 'alterative' / depurative for chronic skin conditions - eczema, psoriasis, acne and boils (internally and topically)
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
Safety, Cautions & Contraindications
Use only standardised, processed seed extract. Raw conkers, leaves and bark contain toxic esculin and can cause poisoning - never eat raw horse chestnut.
May increase bleeding risk, so use caution with anticoagulant/antiplatelet medicines; use caution in kidney disease and avoid in pregnancy and breastfeeding.
As a member of the daisy family (Asteraceae), it can cause allergic reactions in people sensitive to ragweed and related plants. The high inulin content can cause temporary bloating or gas.
May lower blood sugar (caution with antidiabetic medicines) and add to diuretics; avoid medicinal doses in pregnancy.
External Ids
Botanical Description
Large deciduous tree, to 25-30 m, with a broad domed crown and stout, upward-arching branches. The leaves are opposite and palmately compound, with five to seven large, obovate, toothed leaflets radiating from a long stalk. In spring the tree bears large, showy, upright pyramidal flower spikes ('candles') of white flowers marked with yellow or pink at the base. The glossy brown seeds ('conkers') develop inside a spiky green husk and fall in autumn.[1]
Biennial herb closely related to greater burdock, forming a first-year rosette of large, heart-shaped, long-stalked leaves, green above and grey-woolly beneath, generally smaller than Arctium lappa. In the second year it produces a branching flowering stem with smaller purple thistle-like flower heads in a looser, more sprawling habit, each enclosed in a globe of hooked bracts that ripen into clinging burrs.[15]
Habitat
Native to the Balkan Peninsula, and widely planted and naturalised as an ornamental and avenue tree across temperate Europe, North America and elsewhere.[1]
A common weed of waste ground, roadsides, hedgerows and disturbed soil; native to Europe and widely naturalised in North America, where it is often the most common wild burdock species.[15]
Harvesting
The root is dug at the end of the first growing season or early in the second spring, before flowering; leaf may be gathered through the first year. Careful identification against deadly nightshade, whose root can resemble burdock, is essential before digging.[15]
Traditional Uses
Horse chestnut seed has a long folk history as a remedy for varicose veins, haemorrhoids and 'heavy legs', and was also used topically for rheumatic pain and bruising. Modern use is almost exclusively as a standardised seed extract for chronic venous insufficiency, confirming this traditional venous-support reputation.[1]
Preparations
Dosage
Clinical studies commonly use extracts standardised to around 100-150 mg escin daily, in divided doses. Educational reference only, not a prescription.
The EU herbal monograph gives semi-solid dosage forms containing the equivalent of 0.4% triterpene glycosides calculated as protoaescigenin (or, depending on the preparation, 0.85-20% herbal preparation), applied as a thin layer to the affected area 1-3 times daily, in adults and elderly. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- Idris, S. and Mishra, A. and Khushtar, M (2020) 'Phytochemical, ethnomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine', Journal of Basic and Clinical Physiology and Pharmacology, 31(5). doi:10.1515/jbcpp-2019-0115 Meta-analysis / review
https://doi.org/10.1515/jbcpp-2019-0115 - Penaranda Figueredo, F.A. and Vicente, J. and Barquero, A.A. and Bueno, C.A (2024) 'Aesculus hippocastanum extract and the main bioactive constituent beta-escin as antivirals agents against coronaviruses, including SARS-CoV-2', Scientific Reports, 14(1), pp. 6418. doi:10.1038/s41598-024-56759-y Preclinical
https://doi.org/10.1038/s41598-024-56759-y - Idris, S. and Mishra, A. and Khushtar, M (2023) 'Phytochemical Estimation and Therapeutic Amelioration of Aesculus hippocastanum L. Seeds Ethanolic Extract in Gastric Ulcer in Rats Possibly by Inhibiting Prostaglandin Synthesis', Chinese Journal of Integrative Medicine, 29(9), pp. 818-824. doi:10.1007/s11655-023-3734-9 Preclinical
https://doi.org/10.1007/s11655-023-3734-9 - Quarta, S. and Santarpino, G. and Carluccio, M.A. and Calabriso, N. and Scoditti, E. and Siculella, L. and Damiano, F. and Maffia, M. and Verri, T. and De Caterina, R. and Massaro, M (2022) 'Analysis of the Anti-Inflammatory and Anti-Osteoarthritic Potential of Flonat Fast, a Combination of Plant Extracts, Bromelain and Escin (Aesculus hippocastanum), Evaluated in In Vitro Models of Inflammation Relevant to Osteoarthritis', Pharmaceuticals, 15(10), pp. 1263. doi:10.3390/ph15101263 Preclinical
https://doi.org/10.3390/ph15101263 - Owczarek, A. and Kolodziejczyk-Czepas, J. and Wozniak-Serwata, J. and Magiera, A. and Kobiela, N. and Wasowicz, K. and Olszewska, M.A (2021) 'Potential Activity Mechanisms of Aesculus hippocastanum Bark: Antioxidant Effects in Chemical and Biological In Vitro Models', Antioxidants, 10(7), pp. 995. doi:10.3390/antiox10070995 Preclinical
https://doi.org/10.3390/antiox10070995 - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Pittler, M.H. and Ernst, E (2012) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD003230.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub4 - Gallelli, L (2019) 'Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties', Drug Design, Development and Therapy, pp. 3425--3437. doi:10.2147/DDDT.S207720 Preclinical
https://doi.org/10.2147/DDDT.S207720 - Wu, X.J., Zhang, M.L., Cui, X.Y., Gao, F., He, Q., Li, X.J., Zhang, J.W., Fawcett, J.P. and Gu, J.K (2011) 'Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat', Journal of Ethnopharmacology, 139(1), pp. 201--206. doi:10.1016/j.jep.2011.11.003 Preclinical
https://doi.org/10.1016/j.jep.2011.11.003 - European Medicines Agency (HMPC) (2023) 'European Union herbal monograph on Aesculus hippocastanum L., semen, Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/european-union-herbal-monograph-aesculus-hippocastanum-l-semen-final-revision-1_en.pdf - Cheong, D.H.J., Arfuso, F., Sethi, G., Wang, L., Hui, K.M., Kumar, A.P. and Tran, T (2018) 'Molecular targets and anti-cancer potential of escin', Cancer Letters, pp. 1--8. doi:10.1016/j.canlet.2018.02.027 Preclinical
https://doi.org/10.1016/j.canlet.2018.02.027 - Mazrouei, R. and Raeisi, E. and Lemoigne, Y. and Heidarian, E (2019) 'Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and beta-escin on MCF7 Cells', Journal of Medical Signals and Sensors, 9(3), pp. 196-203. doi:10.4103/jmss.JMSS_44_18 Preclinical
https://doi.org/10.4103/jmss.JMSS_44_18 - Yuan, Y. and Wang, P. and Chen, S. and Cao, Z. and Ojha, S.C. and Sun, C. and Wang, G. and Wang, Z. and Gu, J. and Kang, J. and Xue, X (2025) 'Escin inhibits PD-L1 expression by suppressing the p38 MAPK/ERK signalling pathways and synergistically enhances PD-1 inhibitor efficacy in hepatocellular carcinoma', Phytomedicine, 149, pp. 157532. doi:10.1016/j.phymed.2025.157532 Preclinical
https://doi.org/10.1016/j.phymed.2025.157532 - Hussain, Y. and Singh, J. and Meena, A. and Sinha, R.A. and Luqman, S (2023) 'Escin enhanced the efficacy of sorafenib by autophagy-mediated apoptosis in lung cancer cells', Phytotherapy Research, 37(10), pp. 4819-4837. doi:10.1002/ptr.7948 Preclinical
https://doi.org/10.1002/ptr.7948 - Rimmon, A. and Vexler, A. and Berkovich, L. and Earon, G. and Ron, I. and Lev-Ari, S (2013) 'Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway', Biochemistry Research International, 2013, pp. 251752. doi:10.1155/2013/251752 Preclinical
https://doi.org/10.1155/2013/251752 - Domanski, D., Zegrocka-Stendel, O., Perzanowska, A., Dutkiewicz, M., Kowalewska, M., Grabowska, I., Maciejko, D., Fogtman, A., Dadlez, M. and Koziak, K (2016) 'Molecular Mechanism for Cellular Response to beta-Escin and Its Therapeutic Implications', PLoS One, 11(10). doi:10.1371/journal.pone.0164365 Preclinical
https://doi.org/10.1371/journal.pone.0164365 - Gloviczki, M.L., Kakkos, S.K., Urbanek, T., Chuback, J. and Nicolaides, A (2025) 'The role of venoactive compounds in the treatment of chronic venous disease', Journal of Vascular Surgery: Venous and Lymphatic Disorders, 13(5). doi:10.1016/j.jvsv.2025.102258 Preclinical
https://doi.org/10.1016/j.jvsv.2025.102258 - Santiago, F.R., Grillo, L., Amore, M., Carmelino, C., Trejo, J.M.R. and Ulloa, J.H (2026) 'Venoactive drugs in the management of chronic venous disease: A critical appraisal of the evidence and comparison with international guidelines', Vascular Pharmacology. doi:10.1016/j.vph.2026.107614 Preclinical
https://doi.org/10.1016/j.vph.2026.107614 - Pittler, M.H. and Ernst, E (2006) 'Horse chestnut seed extract for chronic venous insufficiency', Cochrane Database of Systematic Reviews, 2006(1), pp. CD003230. doi:10.1002/14651858.CD003230.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD003230.pub3
- Ahangarpour, A., Heidari, H., Oroojan, A.A., Mirzavandi, F., Nasr Esfehani, K. and Dehghan Mohammadi, Z (2017) 'Antidiabetic, hypolipidemic and hepatoprotective effects of Arctium lappa root's hydro-alcoholic extract on nicotinamide-streptozotocin induced type 2 model of diabetes in male mice', Avicenna Journal of Phytomedicine, 7(2), pp. 169-179. Available at: https://pubmed.ncbi.nlm.nih.gov/28348972/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/28348972/ - Gao, Q., Yang, M. and Zuo, Z (2018) 'Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L', Acta Pharmacologica Sinica, 39(5), pp. 787-801. doi:10.1038/aps.2018.32 Traditional / reference
https://doi.org/10.1038/aps.2018.32 - Zeng, F., Li, Y., Zhang, X., Shen, L., Zhao, X. et al (2023) 'Immune regulation and inflammation inhibition of Arctium lappa L. polysaccharides by TLR4/NF-κB signaling pathway in cells', International Journal of Biological Macromolecules, 254, pp. 127700. doi:10.1016/j.ijbiomac.2023.127700 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.127700 - Fischer, S.P.M., Brusco, I., Camponogara, C., Piana, M., Faccin, H., Gobo, L.A., de Carvalho, L.M. and Oliveira, S.M (2017) 'Arctium minus crude extract presents antinociceptive effect in a mice acute gout attack model', Inflammopharmacology, 26(2), pp. 505-519. doi:10.1007/s10787-017-0384-6 Preclinical
https://doi.org/10.1007/s10787-017-0384-6 - Erdemoglu, N., Turan, N.N., Akkol, E.K., Sener, B. and Abacioglu, N (2008) 'Estimation of anti-inflammatory, antinociceptive and antioxidant activities of Arctium minus (Hill) Bernh. ssp. minus', Journal of Ethnopharmacology, 121(2), pp. 318-323. doi:10.1016/j.jep.2008.11.009 Preclinical
https://doi.org/10.1016/j.jep.2008.11.009 - Ilgun, S., Karatoprak, G.S., Polat, D.C., Safak, E.K., Yildiz, G., Kupeli Akkol, E. and Sobarzo-Sanchez, E (2022) 'Phytochemical Composition and Biological Activities of Arctium minus (Hill) Bernh.: A Potential Candidate as Antioxidant, Enzyme Inhibitor, and Cytotoxic Agent', Antioxidants, 11(10), pp. 1852. doi:10.3390/antiox11101852 Preclinical
https://doi.org/10.3390/antiox11101852 - Erol, E., Erol, K.F., Yanikoglu, R.S., Taskin, C., Kizilarslan Hancer, C. and Topcu, G (2024) 'Quantitative Determination of the Cytotoxic Compounds in Different Organs of Arctium minus (Hill) Bernh. by LC-HRESIMS Using Response Surface Methodology', ACS Omega, 9(40), pp. 41890-41903. doi:10.1021/acsomega.4c06644 Preclinical
https://doi.org/10.1021/acsomega.4c06644 - Malanik, M., Farkova, V., Krizova, J., Kresova, A., Smejkal, K., Kasparovsky, T. and Dadakova, K (2024) 'Comparison of Metabolic Profiles of Fruits of Arctium lappa, Arctium minus, and Arctium tomentosum', Plant Foods for Human Nutrition, 79(2), pp. 497-502. doi:10.1007/s11130-024-01175-w Preclinical
https://doi.org/10.1007/s11130-024-01175-w - Cimino, C.V., Colombo, M.L., Liggieri, C., Bruno, M. and Vairo-Cavalli, S (2015) 'Partial Molecular Characterization of Arctium minus Aspartylendopeptidase and Preparation of Bioactive Peptides by Whey Protein Hydrolysis', Journal of Medicinal Food, 18(8), pp. 856-864. doi:10.1089/jmf.2014.0101 Preclinical
https://doi.org/10.1089/jmf.2014.0101 - Kenny, O., Smyth, T.J., Walsh, D., Kelleher, C.T., Hewage, C.M. and Brunton, N.P (2014) 'Investigating the potential of under-utilised plants from the Asteraceae family as a source of natural antimicrobial and antioxidant extracts', Food Chemistry, 161, pp. 79-86. doi:10.1016/j.foodchem.2014.03.126 Preclinical
https://doi.org/10.1016/j.foodchem.2014.03.126 - Karadeniz, A., Alexie, G., Greten, H.J., Andersch, K. and Efferth, T (2015) 'Cytotoxicity of medicinal plants of the West-Canadian Gwich'in Native Americans towards sensitive and multidrug-resistant cancer cells', Journal of Ethnopharmacology, 168, pp. 191-200. doi:10.1016/j.jep.2015.03.052 Preclinical
https://doi.org/10.1016/j.jep.2015.03.052 - Watkins, F., Pendry, B., Sanchez-Medina, A. and Corcoran, O (2012) 'Antimicrobial assays of three native British plants used in Anglo-Saxon medicine for wound healing formulations in 10th century England', Journal of Ethnopharmacology, 144(2), pp. 408-415. doi:10.1016/j.jep.2012.09.031 Preclinical
https://doi.org/10.1016/j.jep.2012.09.031 - Abraham, E.P. and Crowfoot, D.M (1946) 'An antibacterial substance from Arctium minus and Onopordon tauricum', Nature, 158(4021), pp. 744. doi:10.1038/158744a0 Preclinical
https://doi.org/10.1038/158744a0 - Cavallito, C.J. and Kirchner, F.K (1947) 'The antibacterial principle of Arctium minus; the unsaturated lactone structure', Journal of the American Chemical Society, 69(12), pp. 3030-3032. doi:10.1021/ja01204a028 Preclinical
https://doi.org/10.1021/ja01204a028 - Herbal Reality (n.d.) 'Burdock (Arctium): Benefits, Medicinal Uses, Safety'. Available at: https://www.herbalreality.com/herb/burdock/ Traditional / reference
https://www.herbalreality.com/herb/burdock/ - Drugs.com (n.d.) 'Burdock Uses, Benefits & Dosage'. Available at: https://www.drugs.com/npp/burdock.html Traditional / reference
https://www.drugs.com/npp/burdock.html - Chan, Y.S., Cheng, L.N., Wu, J.H., Chan, E., Kwan, Y.W., Lee, S.M.Y., Leung, G.P.H., Yu, P.H.F. and Chan, S.W (2011) 'A review of the pharmacological effects of Arctium lappa (burdock)', Inflammopharmacology, 19(5), pp. 245--254. doi:10.1007/s10787-010-0062-4 Traditional / reference
https://doi.org/10.1007/s10787-010-0062-4 - Bryson, P.D. and Watanabe, A.S. and Rumack, B.H. and Murphy, R.C (1978) 'Burdock root tea poisoning. Case report involving a commercial preparation', JAMA, 239(20), pp. 2157. Available at: https://pubmed.ncbi.nlm.nih.gov/642161/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/642161/ - Berdai, M.A. and Labib, S. and Chetouani, K. and Harandou, M (2012) 'Atropa belladonna intoxication: a case report', Pan African Medical Journal, 11, pp. 72. Available at: https://pubmed.ncbi.nlm.nih.gov/22655106/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22655106/ - Oerlemans, C. and de Vries, I. and van Riel, A.J.H.P (2017) 'Anticholinergic syndrome caused by contaminated herbal tea; acting swiftly to identify the source', Nederlands Tijdschrift voor Geneeskunde, 161, pp. D1261. Available at: https://pubmed.ncbi.nlm.nih.gov/28612694/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/28612694/
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.